3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
115
Brain Neoplasms
114
Prostatic Neoplasms
101
Neoplasm Metastasis
79
Carcinoma, Hepatocellular
69
Lung Neoplasms
67
Pancreatic Neoplasms
64
Breast Neoplasms
48
Melanoma
37
Carcinoma, Renal Cell
33
Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
21
Colorectal Neoplasms
20
Liver Neoplasms
19
Glioblastoma
18
Small Cell Lung Carcinoma
14
Head and Neck Neoplasms
14
Sarcoma
11
Kidney Neoplasms
11
Glioma
10
Recurrence
8
Urinary Bladder Neoplasms
7
Radiation Injuries
6
Neuroma, Acoustic
6
Cholangiocarcinoma
6
Adenocarcinoma
6
Uveal Melanoma
5
Uterine Cervical Neoplasms
5
Prostate Cancer Metastatic
5
Ovarian Neoplasms
5
Interventions
Bevacizumab
17
Capecitabine
13
Cetuximab
10
Oxaliplatin
8
Irinotecan
8
Fluorouracil
7
Panitumumab
5
Leucovorin
4
trifluridine tipiracil drug combination
3
sintilimab
3
regorafenib
3
Nivolumab
3
Ipilimumab
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Folfox protocol
2
Drug Therapy
2
spartalizumab
1
pembrolizumab
1
irinotecan sucrosofate
1
glucopyranosyl lipid-A
1
folfirinox
1
camrelizumab
1
balstilimab
1
anisodamine
1
aflibercept
1
XELOX
1
Vemurafenib
1
Tyrosine Kinase Inhibitors
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colorectal Cancer Metastatic
×
Radiosurgery
×
Clear all
NCT04081168
2022-12-20
COLLISION-XL
Amsterdam UMC, location VUmc
Phase NA
Unknown
68 enrolled